Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Apr 28, 2023 7:34pm
151 Views
Post# 35420333

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How long to BTD and then AA

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How long to BTD and then AAEnrique, doesn't the statement below jibe with what you are saying and we are NOT months away from applying? And of course we should learn more on Sun/Mon after AUA?

It seems like there is always a 3-step process to any news release. First reaction is usually positive followed by a more negative tone and then the "we are on the right track" opinion. I guess that is partly due to the way they release the data.


"The Company is currently working with both a biostatistics and regulatory organization to compile a clinical data report for submission to the FDA in support of the grant of a BTD approval."

enriquesuave wrote:
Rumpl3StiltSkin wrote: Ok Enrique, I agree and that sounds great. Yet I think we get to see this next 3 months data at end of May... Right?

I actually agree. It will be 6 months since November data. So it will show 21 patients or more at 450 days perhaps 


<< Previous
Bullboard Posts
Next >>